Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
Advanced search 
Year : 1995  |  Volume : 16  |  Issue : 2  |  Page : 57-59

Carboplatin for relapsed and resistant acute myeloid leukemia.

Tata Memorial Hospital, Bombay

Correspondence Address:
PSRK Sastry
Tata Memorial Hospital, Bombay

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Eight patients of replased or resistant acute myeloid leukemia were treated with carboplatin in the dose of 1500 mg/m2 over five days. One patient had a complete response and two had partial response. The duration of response was 4-8 months. The toxicity associated with the treatment was significant but manageable and there were two early deaths. The overall response rate was 37.5 percent. We conclude that intravenous carboplatin in the dose used needs further evaluation in the treatment of acute myeloid leukemia.

[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal